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Abstract
Background: The sodium taurocholate co-transporting polypeptide, encoded by SLC10A1, was identified as a
functional receptor for hepatitis B virus (HBV). The objective of this study was to determine if there was an
association of the Ser267Phe variant (rs2296651) with HBV infection status in Moroccan patients.
Methods: Using a TaqMan 5’ allelic discrimination assay, the Ser267Phe variant was genotyped in 286 chronic
hepatitis B patients, 135 individuals with spontaneous clearance from HBV infection and 109 healthy controls
negative for hepatitis B serological markers.
Results: In this cohort, we detected only wild-type genotype (S267S) in all groups. This polymorphism was not
associated with the HBV infection status in Moroccan patients.
Conclusions: The S267F variant is absent among Moroccans regardless of chronic HBV infection status.
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Background
Chronic hepatitis B (CHB) affects about 248 million people
worldwide and can lead to liver cirrhosis, liver failure and he-
patocellular carcinoma, especially in many Asian and African
countries [1, 2]. Whereas around 90% of the HBV-infected
adults develop acute infection followed by spontaneous viral
clearance, 5–10% of infected individuals are not able to clear
the virus and develop chronic infection [3, 4]. Morocco is a
country of intermediate endemicity of hepatitis B virus
(HBV) and diverse modes of transmission including vertical,
intra-familial, sexual or parenteral have been reported [5].
Several studies have highlighted that host genetic factors
could influence the course of the disease [6, 7]. Recently, Yan
and colleagues identified sodium taurocholate cotransporting
polypeptide (NTCP) as a functional receptor of HBV [8].
NTCP is a member of the solute carrier family 10 (SLC10),
the major bile acid uptake system in human hepatocytes, and
localized to the basolateral hepatocyte membrane [9].
Silencing the NTCP expression in primary Tupaia hepato-
cytes, HepaRG or primary human hepatocytes diminished
HBV infectivity [8]. A genetic polymorphism (S267F,
c.800G>A, rs2296651) in the solute carrier family 10 mem-
ber 1 gene (SLC10A1) completely abolished the HBV recep-
tor function of human NTCP [10]. In addition, a previous
study showed that the S267F mutant of NTCP had normal
cell surface expression, but resulted in almost complete loss
of bile salt uptake [11]. Starting from this known functional
polymorphism, some case control association studies on
HBV infection were conducted among Asian patients. How-
ever, the results were not consistent [12–15].
The aim of this study was to determine whether the
SLC10A1 rs2296651 (S267F) polymorphism was associated
with resolution or the progression of hepatitis B in patients
from Morocco.
* Correspondence: sayeh.ezzikouri@pasteur.ma
1Virology Unit, Viral Hepatitis Laboratory, Institut Pasteur du Maroc, 1, Place
Louis Pasteur, 20360 Casablanca, Morocco
Full list of author information is available at the end of the article
© The Author(s). 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Ezzikouri et al. BMC Infectious Diseases  (2017) 17:99 
DOI 10.1186/s12879-017-2214-2
Methods
To address this issue, a total of 530 consented Moroccan
participants were independently recruited at Institut Pasteur
du Maroc. From May 2008 through January 2015, 286 CHB
patients (172 males) with a median age of 42 years (range
19–78), 135 (52 males) individuals with spontaneous clear-
ance from HBV infection, who were positive for antibody
against hepatitis B core antigen and negative for hepatitis B
surface antigen (HBsAg), with a median age of 52 years
(range 19–85) and 109 healthy controls (55 males) negative
for hepatitis serological markers with a median age of
53 years (range 25–76) were enrolled in the present study.
The study was approved by the Ethics Committee of the
Faculté de Medicine of Casablanca. The rs2296651 poly-
morphism was genotyped using a TaqMan SNP Genotyping
Assay (Applied Biosystems; assay ID C_16184554_10). Ap-
proximately 15% of total DNA samples were repeated for
quality control, and no discrepancy was observed.
Results & discussion
We investigated the association between the serine/
phenylalanine polymorphism located at codon 267 of
SLC10A1 and HBV infection status in a case-control
study of 286 CHB and 135 subjects with spontaneous
clearance from HBV infection. Moreover, to estimate the
frequencies of the SLC10A1 genotypes in the general
Moroccan population, the rs2296651 was genotyped in
109 healthy controls. The demographic, biochemical and
virological characteristics of the population studied are
shown in Table 1. In this cohort, we detected only wild-
type genotype (S267S) in all groups and there were no
differences between groups. Our finding is in contrast
with previous asian studies, and suggest that this
polymorphism may be specific to Asian populations. A
recent large cohort study showed that heterozygous and
homozygous subjects for S267F polymorphism were re-
sistant to CHB [12]. Moreover, other findings support
this association and showed that S267F homozygotes
were strongly associated with HBsAg-seronegativity [13].
However, other previous studies showed that the S267F
variant was associated with susceptibilty to HBV infec-
tion [14, 16]. Furthermore, a recent report found that
the frequency of the mutant allele was decreased in the
positive HBsAg group and increased in HBsAg and
HBeAg positive groups relative to controls [15].
Conclusions
Our data showed that S267F is not associated with HBV
infection, and is not prevalent in the general Moroccan
population.
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clearance (N = 135)
Healthy controls
(N = 109)
Median age (range), y 42 (19–78) 52 (19–85) 53 (25–76)
Gender (%)
Male 60.14 38.51 50.46
Female 39.86 61.49 49.54
Mean Alanine aminotransferase ±
SD (IU/L)
55.66 ± 25.63 28.36 ± 6.32 26.80 ± 5.72
Mean Aspartate aminotransferase ±
SD (IU/L)
48.09 ± 24.87 25.93 ± 5.45 21.70 ± 2.64
HBeAg positive (%) 5.5 – –
Anti-HBe positive (%) 94.5 – –
Median log10 HBV-DNA (IU/ml) 4.4 (3.8-6.5) – –
Genotypes (%)
D 89 – –
A 11 – –
SLC10A1 (rs2296651, G > A)
GG 286 (100%) 135 (100%) 109 (100%)
AG 0 0 0
AA 0 0 0
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